TheEdgeResearch
Home / Stocks / NTRR

Neutra Corp. (NTRR)

OTC Healthcare Biotechnology
$0.00 ▲ +0.00%
Market Cap
$291,790
Sector
Healthcare
Industry
Biotechnology
Beta
1.49
52-Wk Range
0.000099999997-0.0003
CEO
Sydney Jim
Country
US
Currency
USD

Neutra Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Houston, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $291,790. On trailing twelve-month figures it carries a trailing P/E of 1.00, a net margin of 77.0%. Its beta of 1.49 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
1.00
Price / Sales
0.23
Price / Book
-1.69
EV / EBITDA
0.31
Gross margin
70.8%
Operating margin
83.1%
Net margin
77.0%
Return on equity
—
Debt / equity
-0.67
Current ratio
0.43
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
15
IPO date
2011-10-12
Headquarters
Houston, TX, US
About Neutra Corp.

Neutra Corp. specializes in the research, development, and provision of hemp-derived nutraceuticals. Its product portfolio features items such as CBD-infused sports creams, in addition to a variety of other health and wellness goods. Established in 2011, the company is headquartered in Sugar Land, Texas.

Comparable companies

Neutra Corp. is most often compared with the following Healthcare names:

BIORBPTHCATVEMMAHALBHXBMMRZMORGSOXIHFUNBX
More research on NTRR
NTRR technical analysis NTRR TheEdge Score Compare against peers
Open full interactive analysis & DCF →